Complement Therapeutics

Unwin, R. (Academic founder)

Division of Cancer Sciences (L5)

Activity: Consultancy, spin-outs, CPD & licensing › Spin-outs & start-ups › Research

Description

Academic founder and director of CTx, a vehicle for development of a number of complement targeting therapies and associated companion diagnostic assays.

Period	2020 → …
Work for	The University of Manchester I3 Ltd, United Kingdom